The goal of our webinars is to provide direct answers to people with ALS, their families and others involved or interested in research leading to the development of effective treatments and cures for ALS.
This session will review the three Phase 3 trials enrolling people with ALS in the US/EU right now: NurOwn, levosimendan, and arimoclomol as well as major Phase 2 trials, such as reldesemtiv. |